Viewing Study NCT04743661


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2025-12-30 @ 11:52 AM
Study NCT ID: NCT04743661
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-06
First Post: 2021-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Sponsor: Pediatric Brain Tumor Consortium
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module